JP2014513094A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513094A5 JP2014513094A5 JP2014508441A JP2014508441A JP2014513094A5 JP 2014513094 A5 JP2014513094 A5 JP 2014513094A5 JP 2014508441 A JP2014508441 A JP 2014508441A JP 2014508441 A JP2014508441 A JP 2014508441A JP 2014513094 A5 JP2014513094 A5 JP 2014513094A5
- Authority
- JP
- Japan
- Prior art keywords
- hcl
- acid
- peg
- agent
- pharmaceutical agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161480259P | 2011-04-28 | 2011-04-28 | |
| US61/480,259 | 2011-04-28 | ||
| PCT/US2012/034361 WO2012148799A1 (en) | 2011-04-28 | 2012-04-20 | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016208029A Division JP2017014293A (ja) | 2011-04-28 | 2016-10-24 | 親油性医薬用薬剤の改良された非経口製剤ならびにそれを調製および使用するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513094A JP2014513094A (ja) | 2014-05-29 |
| JP2014513094A5 true JP2014513094A5 (enExample) | 2015-03-26 |
| JP6080312B2 JP6080312B2 (ja) | 2017-02-15 |
Family
ID=46045121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014508441A Active JP6080312B2 (ja) | 2011-04-28 | 2012-04-20 | 親油性医薬用薬剤の改良された非経口製剤ならびにそれを調製および使用するための方法 |
| JP2016208029A Pending JP2017014293A (ja) | 2011-04-28 | 2016-10-24 | 親油性医薬用薬剤の改良された非経口製剤ならびにそれを調製および使用するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016208029A Pending JP2017014293A (ja) | 2011-04-28 | 2016-10-24 | 親油性医薬用薬剤の改良された非経口製剤ならびにそれを調製および使用するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US9364433B2 (enExample) |
| EP (2) | EP3238709B1 (enExample) |
| JP (2) | JP6080312B2 (enExample) |
| CN (2) | CN103635179B (enExample) |
| AR (1) | AR086115A1 (enExample) |
| AU (1) | AU2012250050B2 (enExample) |
| CA (1) | CA2834262C (enExample) |
| DK (2) | DK2701684T3 (enExample) |
| ES (2) | ES2640572T3 (enExample) |
| HU (2) | HUE034480T2 (enExample) |
| IL (1) | IL229067B (enExample) |
| MX (2) | MX380805B (enExample) |
| PL (2) | PL2701684T3 (enExample) |
| TW (1) | TWI626059B (enExample) |
| WO (1) | WO2012148799A1 (enExample) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| CN102686205A (zh) | 2009-10-02 | 2012-09-19 | 弗艾米克斯有限公司 | 局部四环素组合物 |
| RU2734128C2 (ru) * | 2010-12-16 | 2020-10-13 | Плэтформ Брайтворкс Ту,Лтд | Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям |
| CN103635179B (zh) * | 2011-04-28 | 2017-12-29 | 普拉福姆五金器具第二有限公司 | 亲脂性药剂的改进的胃肠外制剂以及制备和使用其的方法 |
| US20140178479A1 (en) * | 2011-08-12 | 2014-06-26 | Perosphere, Inc. | Concentrated Felbamate Formulations for Parenteral Administration |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
| GR20120100242A (el) * | 2012-05-04 | 2014-01-02 | Micrel Ιατρικα Μηχανηματα Α.Ε., | Αντλια και προγεμισμενος ασκος/σετ αναλγησιας |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| EP3045169B1 (en) | 2013-09-13 | 2018-05-02 | Akiko Itai | Aqueous solution formulation, and manufacturing method for same |
| CN105939699B (zh) | 2013-12-03 | 2020-10-02 | 西北大学 | 脂质体颗粒、制备所述脂质体颗粒的方法以及其用途 |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| US11696883B2 (en) | 2014-05-23 | 2023-07-11 | Triple Hair Inc. | Compositions for reducing hair loss and/or increasing hair regrowth |
| CA2903734C (en) | 2014-05-23 | 2016-03-01 | Houfar SEKHAVAT | Compositions for reducing hair loss and/or increasing hair regrowth |
| US10434064B2 (en) | 2014-06-04 | 2019-10-08 | Exicure, Inc. | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| CN105394045B (zh) * | 2014-09-04 | 2020-02-14 | 中国科学院上海巴斯德研究所 | 一种肠道病毒的小分子化合物抑制剂及其应用 |
| US11266621B1 (en) | 2014-10-02 | 2022-03-08 | Exela Sterile Medicines Llc | Methocarbamol composition and related methods |
| WO2016059590A1 (en) * | 2014-10-16 | 2016-04-21 | Piramal Enterprises Limited | Stable injectable composition of small molecule drugs and process for its preparation |
| TWI516520B (zh) | 2014-10-31 | 2016-01-11 | 財團法人工業技術研究院 | 波長轉換聚合物、其製法及包含其之波長轉換裝置 |
| EP3347009B1 (en) | 2015-07-08 | 2021-10-13 | Triple Hair Inc. | Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US20170239250A1 (en) | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| CN105837556B (zh) * | 2016-04-11 | 2018-10-26 | 上海工程技术大学 | 一种来那度胺与烟酰胺共晶的制备方法 |
| ES2937307T3 (es) | 2016-07-26 | 2023-03-27 | Univ Southern California | Inhibición selectiva del bromodominio del BDF1 fúngico |
| WO2018042352A1 (en) * | 2016-08-31 | 2018-03-08 | Taro Pharmaceutical Industries | Fenoldopam topical formulations for treating skin disorders |
| CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| CN106841100A (zh) * | 2016-12-28 | 2017-06-13 | 北京医药集团有限责任公司 | 一种基于近红外光谱技术的小规格口服固体制剂中活性药物成分快速测定方法 |
| MA48047A (fr) * | 2017-04-05 | 2020-02-12 | Modernatx Inc | Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée |
| CA3059435A1 (en) * | 2017-04-12 | 2018-10-18 | Synergistic Therapeutics, Llc | Therapeutic neuropathic pain lotion |
| EP3638215A4 (en) | 2017-06-15 | 2021-03-24 | Modernatx, Inc. | RNA FORMULATIONS |
| CN111315359A (zh) | 2017-08-31 | 2020-06-19 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| WO2020061457A1 (en) | 2018-09-20 | 2020-03-26 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| EP3866783A4 (en) * | 2018-10-16 | 2022-08-03 | US Nano Food & Drug Inc | INTRATUMOR INJECTION FORMULATION |
| WO2020087031A1 (en) | 2018-10-26 | 2020-04-30 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| US20210369669A1 (en) * | 2018-10-31 | 2021-12-02 | Systamedic Inc. | Autophagy activators and inhibitors of ferroptosis for preventing acute renal failure and neurotoxcity induced by certain antibiotics |
| CN109627148B (zh) * | 2018-11-28 | 2021-09-03 | 中国农业科学院麻类研究所 | 一种大麻二酚的制备方法、制得的大麻二酚及其用途 |
| BR112021017140A2 (pt) | 2019-03-08 | 2021-11-09 | Taro Pharma Ind | Composições tópicas estáveis de fenoldopam |
| CN113874502A (zh) | 2019-03-11 | 2021-12-31 | 摩登纳特斯有限公司 | 补料分批体外转录方法 |
| US20220387416A1 (en) * | 2019-10-25 | 2022-12-08 | Cmc Pharmaceuticals, Inc. | Atropine-scopolamine with enhanced stability |
| JP2023505189A (ja) * | 2019-12-04 | 2023-02-08 | レスク ファーマシューティカルズ エルエルシー | 経口利尿薬に不応性の浮腫を処置するための方法及び組成物 |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| CN114181211B (zh) * | 2020-09-14 | 2024-05-28 | 鲁南制药集团股份有限公司 | 一种酮咯酸与苯甲酰胺共晶体及其制备方法 |
| CN112697945A (zh) * | 2020-12-18 | 2021-04-23 | 卓和药业集团有限公司 | 泊沙康唑肠溶片含量的分析方法 |
| CN113274379B (zh) * | 2021-05-25 | 2023-04-25 | 湖北工业大学 | Bephenium Hydroxynaphthoate在制备抗EV71药物的应用 |
| CN113768937B (zh) * | 2021-11-15 | 2022-04-08 | 恒翼生物医药科技(上海)有限公司 | 用于降低尿酸水平的化合物 |
| MX2024008162A (es) * | 2021-12-27 | 2024-09-17 | Enalare Therapeutics Inc | Formulaciones parenterales estimulantes respiratorias. |
| CN115721607B (zh) * | 2022-11-19 | 2023-07-21 | 华夏生生药业(北京)有限公司 | 一种乳酸左氧氟沙星注射液及其制备方法 |
| US20250032417A1 (en) | 2023-07-24 | 2025-01-30 | Hyloris Developments Sa | Lyophilized metolazone formulation for parenteral administration |
| WO2025054148A1 (en) * | 2023-09-07 | 2025-03-13 | Cfd Research Corporation | Co-administration of astemizole and an anticancer agent to treat cancer |
| CN118121554A (zh) * | 2024-03-14 | 2024-06-04 | 天津市保灵动物保健品有限公司 | 盐酸特比萘芬片剂 |
| CN119499175A (zh) * | 2024-11-23 | 2025-02-25 | 江西赣南海欣药业股份有限公司 | 一种注射用法莫替丁及其制备方法 |
| CN119951294B (zh) * | 2025-02-14 | 2025-12-16 | 内蒙古优然牧业有限责任公司 | 一种用于牧场的生物除臭剂及其制备方法 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS475827Y1 (enExample) | 1970-04-02 | 1972-02-29 | ||
| JPS475827A (enExample) * | 1971-08-27 | 1972-03-29 | ||
| AU461715B2 (en) * | 1972-01-21 | 1975-05-19 | American Home Products Corporation | Parenteral benzodiazepine compositions |
| DE3316510A1 (de) | 1983-05-06 | 1984-11-08 | Bayer Ag | Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen |
| US4912124A (en) | 1984-02-23 | 1990-03-27 | Ortho Pharmaceutical Corporation | Antifungal dermatological solution |
| DE3702105A1 (de) | 1987-01-24 | 1988-08-04 | Bayer Ag | Parenterale loesung |
| JPH01242525A (ja) | 1988-03-25 | 1989-09-27 | Nippon Nohyaku Co Ltd | 抗真菌外用剤 |
| US5430057A (en) * | 1993-09-30 | 1995-07-04 | Board Of Regents, The University Of Texas System | Parenteral busulfan for treatment of malignant disease |
| US5869474A (en) * | 1997-05-16 | 1999-02-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Low dosage treatment for cocaine craving and withdrawal |
| US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US7179475B1 (en) | 1998-12-04 | 2007-02-20 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| AU5273200A (en) * | 1999-05-24 | 2000-12-12 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| CN1174741C (zh) * | 1999-09-21 | 2004-11-10 | Rtp药品公司 | 生物活性物质的表面改性微粒组合物 |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| GB2365770B (en) | 2000-08-18 | 2002-07-31 | Diomed Dev Ltd | Antifungal ketoconazole composition for topical use |
| US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| US20030072807A1 (en) | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
| JP2002322056A (ja) | 2001-04-27 | 2002-11-08 | Nippon Kayaku Co Ltd | トリアゾール誘導体の溶液製剤 |
| US20050191359A1 (en) * | 2001-09-28 | 2005-09-01 | Solubest Ltd. | Water soluble nanoparticles and method for their production |
| US6878693B2 (en) | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
| US6991800B2 (en) | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
| AU2003249510A1 (en) | 2002-08-12 | 2004-02-25 | Ranbaxy Laboratories Limited | A parenteral dosage form of selective cox-2 inhibitors |
| ZA200409537B (en) | 2003-01-31 | 2006-10-25 | Yamanouchi Pharma Co Ltd | Stable solid medicinal composition for oral administration |
| US9259390B2 (en) * | 2003-08-13 | 2016-02-16 | The University Of Houston System | Parenteral and oral formulations of benzimidazoles |
| GB0412866D0 (en) | 2004-06-09 | 2004-07-14 | Novartis Ag | Organic compounds |
| FR2872703B1 (fr) | 2004-07-07 | 2006-10-06 | Ethypharm Sa | Nanoparticules polymeriques composites |
| US20060116404A1 (en) | 2004-09-24 | 2006-06-01 | Gary Robinson | CAI-based systems and methods for the localized treatment of ocular and other diseases |
| JP2008534610A (ja) | 2005-03-31 | 2008-08-28 | ブリストル−マイヤーズ スクイブ カンパニー | イクサベピロンの投与方法 |
| CA2613389A1 (en) | 2005-06-27 | 2007-01-04 | Barrier Therapeutics, Inc. | Micogel topical formulations |
| ITMI20051826A1 (it) | 2005-09-29 | 2007-03-30 | Novachem S A | Kit per la somministrazione parenterale di medicamenti |
| WO2007047253A2 (en) | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| CA2626016A1 (en) | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| AU2007206582B2 (en) | 2006-01-23 | 2011-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Microspheres comprising nanocapsules containing a lipophilic drug |
| US20070249546A1 (en) * | 2006-04-22 | 2007-10-25 | Sawaya Assad S | Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them |
| US20100160442A1 (en) * | 2006-07-18 | 2010-06-24 | Ossovskaya Valeria S | Formulations for cancer treatment |
| AU2007355106A1 (en) | 2006-11-29 | 2008-12-18 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| WO2009031642A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
| EP2200588B1 (en) | 2007-09-25 | 2019-03-20 | Solubest Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
| US20090253712A1 (en) | 2008-04-03 | 2009-10-08 | Semmelweis Egyetem | Aqueous solvent system for solubilization of azole compounds |
| WO2009139925A1 (en) | 2008-05-16 | 2009-11-19 | Panacea Pharmaceuticals, Inc. | Methods for the treatment of brain edema |
| SG173183A1 (en) | 2009-02-05 | 2011-09-29 | Targeted Delivery Technologies Ltd | Methods of reducing the proliferation and viability of microbial agents |
| US10130610B2 (en) | 2009-04-09 | 2018-11-20 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US8252821B2 (en) | 2009-04-14 | 2012-08-28 | Bristol-Myers Squibb Company | Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound |
| US20100280031A1 (en) * | 2009-04-30 | 2010-11-04 | Paul David | Lipid formulation of apoptosis promoter |
| RU2734128C2 (ru) * | 2010-12-16 | 2020-10-13 | Плэтформ Брайтворкс Ту,Лтд | Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям |
| CN103635179B (zh) * | 2011-04-28 | 2017-12-29 | 普拉福姆五金器具第二有限公司 | 亲脂性药剂的改进的胃肠外制剂以及制备和使用其的方法 |
-
2012
- 2012-04-20 CN CN201280032690.8A patent/CN103635179B/zh active Active
- 2012-04-20 HU HUE12719541A patent/HUE034480T2/en unknown
- 2012-04-20 MX MX2018013788A patent/MX380805B/es unknown
- 2012-04-20 EP EP17175794.1A patent/EP3238709B1/en active Active
- 2012-04-20 CN CN201711217375.3A patent/CN107970209B/zh active Active
- 2012-04-20 JP JP2014508441A patent/JP6080312B2/ja active Active
- 2012-04-20 MX MX2013012579A patent/MX360638B/es active IP Right Grant
- 2012-04-20 DK DK12719541.0T patent/DK2701684T3/en active
- 2012-04-20 PL PL12719541T patent/PL2701684T3/pl unknown
- 2012-04-20 AU AU2012250050A patent/AU2012250050B2/en active Active
- 2012-04-20 WO PCT/US2012/034361 patent/WO2012148799A1/en not_active Ceased
- 2012-04-20 US US13/452,033 patent/US9364433B2/en active Active
- 2012-04-20 ES ES12719541.0T patent/ES2640572T3/es active Active
- 2012-04-20 ES ES17175794T patent/ES2822350T3/es active Active
- 2012-04-20 DK DK17175794.1T patent/DK3238709T3/da active
- 2012-04-20 EP EP12719541.0A patent/EP2701684B1/en active Active
- 2012-04-20 HU HUE17175794A patent/HUE051400T2/hu unknown
- 2012-04-20 PL PL17175794T patent/PL3238709T3/pl unknown
- 2012-04-20 CA CA2834262A patent/CA2834262C/en active Active
- 2012-04-25 TW TW101114722A patent/TWI626059B/zh active
- 2012-04-26 AR ARP120101455A patent/AR086115A1/es not_active Application Discontinuation
-
2013
- 2013-10-24 IL IL229067A patent/IL229067B/en active IP Right Grant
-
2016
- 2016-05-13 US US15/154,919 patent/US9724345B2/en active Active
- 2016-10-24 JP JP2016208029A patent/JP2017014293A/ja active Pending
-
2017
- 2017-03-07 US US15/451,748 patent/US10028949B2/en active Active
-
2018
- 2018-06-21 US US16/014,908 patent/US10548890B2/en active Active
-
2020
- 2020-01-17 US US16/746,460 patent/US11045466B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513094A5 (enExample) | ||
| US11045466B2 (en) | Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same | |
| US9801855B2 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| AU2008303129B2 (en) | Compositions comprising lipophilic active compounds and method for their preparation | |
| US20200206139A1 (en) | Compositions for the improved delivery of drugs | |
| US20200405643A1 (en) | Drug compositions containing porous carriers made by thermal or fusion-based processes | |
| US20230338300A1 (en) | Pharmaceutical composition containing cocrystals for additive manufacturing | |
| US20230218533A1 (en) | 3d laser sintering processes for improved drug delivery | |
| US20210129406A1 (en) | Drug solvates in thermal processes to make solid dispersions at lower processing temperatures | |
| US20230167181A1 (en) | Pharmaceutical compositions and methods of manufacture using thermally conductive excipients | |
| HK1193026B (en) | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same | |
| HK1193026A (en) | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same | |
| HK1145639B (en) | Compositions comprising lipophilic active compounds and method for their preparation |